Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Toxicokinetics Test Service Company

2020-06-18
|
Page View:

ADME” or “Toxicokinetics” is the process of studying the body’s absorption, distribution, metabolism, and excretion of foreign chemicals.

Medicilon Drug Safety Evaluation Service>>

Toxicokinetics Test Service
Toxicokinetic absorption, distribution, metabolism, excretion

The toxicokinetics study used repeated doses of the toxicity test dose to study the dynamic changes of drugs in vivo, and obtained pharmacokinetic data. It is usually carried out in conjunction with repeated administration of toxicity tests. If appropriate parameters are determined, repeated tests can be avoided. Toxicokinetics is an integral part of the design of non-clinical trials. In understanding the results of toxicity studies and comparing them with clinical data to evaluate safety for humans, the focus is on interpreting the results of toxicity tests and increasing the value of safety assessment data. The purpose of the toxicokinetics study is to know the degree and duration of systemic exposure of the test substance at different dose levels in the toxicity test, and to predict the potential risk of the test substance in human exposure.

At present, the Medicilon Toxicokinetics Test Center has carried out comprehensive reproductive toxicity tests (paragraphs I, II, III), genotoxicity tests (Ames, micronucleus, chromosome aberrations), local toxicity tests, immunogenicity tests, Studies on safety pharmacology, toxicokinetics, carcinogenesis, etc.

The main values of toxicokinetics research in safety evaluation are:
(1) Describe the systemic exposure of the test substance and/or its metabolites in the toxicity test and its dose and time relationship with the toxic reaction; evaluate the test substance and/or its metabolite in different animal species, sex, age, Toxicity of body status (eg pregnancy status); Evaluate the rationality of animal species selection and medication regimen for non-clinical toxicity studies.
(2) Improve the predictive value of animal toxicity test results for clinical safety evaluation. Evaluating the target site toxicity (such as liver or kidney toxicity) caused by the accumulation of the test substance based on the exposure amount helps to provide quantitative safety information for the subsequent safety evaluation.
(3) Comprehensive drug efficacy and exposure and toxicity and exposure information to guide the design of human trials, such as initial dose, safety range evaluation, etc., and guide clinical safety monitoring according to the degree of exposure.

Exposure Assessment Services

  • Plasma protein binding

  • Tissue uptake

  • Receptor properties

  • Species differences in metabolic characteristics

  • Pharmacological activity of metabolites

  • Immunogenicity and toxicology

Research Content of Pharmacokinetics and Toxicokinetics:

Test typeAnimal speciesDrug typeRoute of administrationresearch content
Pharmacy / PoisonMice

Rat

Guinea pig

Rabbit

Beagles
Small molecule

Biological

Natural products

Vaccine

Traditional Chinese medicine
Oral: gavage, capsule

Parenteral: intraperitoneal injection, intravenous injection, intramuscular injection, intradermal injection, subcutaneous injection, continuous infusion, intravitreal injection

Others: nasal feeding, nasal cavity, eyes, rectum, vagina, implantation
Drug absorption, distribution, metabolism and excretion

PK/TK

Bioequivalence

Bioavailability (po, sc, im, ip, etc.)

Organizational distribution

PK/PD study of a rodent disease model for dose design and dosing regimen

PK research on the development and evaluation of pharmaceutical preparations

Special PK studies, including food effects, gender factors, drug interactions, and the effect of gastric pH on drug PK

Plasma protein binding (equilibrium dialysis and ultrafiltration)

Our Staff

  1. Design the dosing regimen of the toxicokinetic test

  2. Collect samples in time according to the frequency required for exposure assessment

  3. Analysis of analyte and biological matrix (biological fluid or tissue)

  4. Data statistics and evaluation

  5. Write an experimental report based on complete toxicokinetic data

Toxicokinetic test


contact us
Email: marketing@medicilon.com

Phone: 021 58591500

Related Articles:

Medicilon Drug Metabolite Analysis Service

Medicilon Metabolomics Technical Services

Pharmacokinetic Research Services

Medicilon Drug Impurity Analysis Service

What is Toxicokinetics?

Return
Relevant newsRelevant news